Decision: Favourable

Decisions Table

Study Title:

A double blind, randomized, placebo-controlled trial evaluating the efficacy and safety of BI 1015550 over at least 52 weeks in patients with Idiopathic Pulmonary Fibrosis (IPF)

  • NREC Code:

    22-NREC-CT-158

  • Decision:

    Favourable

  • Meeting Date:

    19/10/2022

  • Study Type:

    NREC CT

  • Principal Investigator:

    Prof. Michael P. Keane

  • PI Institution:

    St. Vincent's University Hospital

  • Sponsor:

    Boehringer Ingelheim International GmbH

Scroll to Top